// company-profile

Aclaris Therapeutics, Inc.

ACRS
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings113Insiders18
// api This Aclaris Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 24 insiders purchased shares. Buying was led by Molineaux Christopher P..

// 90-day insight

Over the last 90 days, Aclaris Therapeutics, Inc. insiders bought $0 (26 transactions) and sold $1.4M (2 transactions).

  • Most active insider: Molineaux Christopher P. with 4 transactions totaling $0.
  • Largest single sale: $1.4M by Leonard Braden Michael on Apr 23, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Aclaris Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$393.9M
QoQ change
+74.6%
Reporting period
2026-03-31
#1
BML Capital Management, LLC
CIK 1616824
$53.4M
14.3M shares
#2
Deep Track Capital, LP
CIK 1856083
$35.0M
9.3M shares
#3
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$25.5M
6.8M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 5, 2026Molineaux Christopher P.ACRS
Option Exercise
11,580
Jun 5, 2026GOWEN MAXINEACRS
Option Exercise
11,580$0.00$0K
Jun 5, 2026MILANO VINCENTACRS
Option Exercise
11,580$0.00$0K
Jun 5, 2026MILANO VINCENTACRS
Option Exercise
11,580
Jun 5, 2026Humphries William D.ACRS
Option Exercise
11,580$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.